98%
921
2 minutes
20
The Tri-County Detroit Area (TCDA) is the 12th most populous metropolitan area in the United States with over three million people. Multiple communicable diseases are endemic in the TCDA. In 2017, to explore innovative methods that may provide early warnings of outbreaks affecting populations in the TCDA, an exploratory partnership that was funded by a U.S. National Science Foundation Early-concept Grant for Exploratory Research (EAGER) began. Since 2017, a project team including the College of Engineering at Michigan State University (MSU), the City of Detroit, the Great Lakes Water Authority (GLWA), industry, and local government and health departments, has been testing municipal wastewater from the TCDA to survey and predict surges in communicable diseases in the area. This ongoing effort started years before wastewater-based epidemiology became a widespread method in public health practice, due to the COVID-19 pandemic, and is now supported by the U.S. Centers for Disease Control and Prevention (CDC). The work of the partnership led to significant breakthroughs in the field of wastewater surveillance/wastewater epidemiology. The results of our surveillance efforts are used to assist local health departments in their understanding and response efforts for health issues in the TCDA, facilitating public health messaging for local awareness, targeted clinical testing, and increased vaccination efforts. Our data are available to the local health departments, and our methodological advancements are published and have been used by other communities nationwide and beyond. This paper describes the partnership, lessons learned, significant achievements, and provides a look into the future. The successful implementations and advancements of wastewater surveillance in the TCDA advocate the importance of frequent communications and interactions within the partnership, idea generations from each stakeholder for decision-making, maintenance of scientific rigor, ethical awareness, and more.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11810916 | PMC |
http://dx.doi.org/10.3389/fpubh.2024.1475425 | DOI Listing |
J Med Internet Res
September 2025
Institute of Hospital Management, Peking University Third Hospital, Beijing, China.
Background: Telemedicine is developing rapidly, presenting new opportunities and challenges for physicians and patients. Limited research has examined physicians' behavior during the process of adopting telemedicine and related factors.
Objective: This study aimed to identify perceived barriers and enablers of physicians' adoption of telemedicine and to develop intervention strategies.
JAMA Pediatr
September 2025
Department of Pediatrics and Emergency Medicine, Children's National Hospital, George Washington University, Washington, DC.
Importance: Adolescents account for almost half of the 2.5 million diagnosed sexually transmitted infections in the US annually, and the emergency department functions as the primary source of health care for many adolescents. No recommendations exist for emergency department gonorrhea and chlamydia screening.
View Article and Find Full Text PDFJ Neurosurg Anesthesiol
September 2025
Anesthesiology, University of Michigan, Ann Arbor, MI.
Background: Carotid blowout syndrome (CBS) is a life-threatening emergency involving the rupture of the carotid arteries and/or branches, often following surgery and radiotherapy for head and neck cancer. Our case series aimed to describe airway management strategies, endovascular and surgical approaches, perioperative resuscitation management, and clinical outcomes in a cohort of patients with CBS at a tertiary referral academic health center.
Methods: We retrospectively identified patients presenting with CBS between 2017 and 2021.
Palliat Med Rep
June 2025
Department of Palliative Medicine, Tan Tock Seng Hospital, Singapore, Singapore.
Background: Goals of care (GOC) discussions align medical care with patients' wishes. Many physician-associated barriers to GOC discussions have been identified, but there is little understanding of the lived experiences of patients and their nominated health care spokespersons (NHSs) who have participated in the discussion.
Objectives: We aimed to describe the lived experience of participants of GOC discussions conducted during acute inpatient care and identify the features of well-conducted GOC discussions.
Can Commun Dis Rep
August 2025
Public Health Agency of Canada, Montréal, QC.
Background: The COVID-19 antiviral Nirmatrelvir/Ritonavir (Paxlovid, N/R) was approved for use in Canada in January 2022, with the Government of Canada assuming a procurement role and provinces, territories, and federal departments implementing usage within their respective healthcare systems. The objective of this analysis is to describe how N/R was implemented across various jurisdictions in the first six months after it was available for use and identify promising implementation practices.
Methods: Fourteen semi-structured discussions in small group settings were conducted with jurisdictional representatives involved in the implementation of N/R.